- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00802490
Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD (EEG)
Pilot Trial of a Brain-computer Interface System Based Programme for the Treatment of ADHD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will enroll 20 outpatient subjects aged 7 to 12 newly diagnosed with ADHD who have never received treatment with medication. These children should have inattentive symptoms, i.e. diagnosed with combined or inattentive subtype of ADHD, and should not have any of the exclusion criteria. Based on the gender ratios from other studies, we will enroll 8 boys and 2 girls into the intervention group, giving a male:female ratio of 4:1. 10 will be in the 'intervention' group and 10 in the 'control' group.
Informed consent will be obtained from the parents, and assent from the subjects, prior to any form of assessment or intervention as part of the study.
INTERVENTION
The 10 subjects in the intervention group will take part in a total of 20 sessions spread over a 10-week period. Each subject will first need to master a simple concentration task involving a fishing game. After this, the child will go on to play a second soccer game. Each game employs the BCI system, and is controlled by the child's concentration, which is fed to the computer via the EEG leads. The child watches the game on a computer screen. Each session may take approximately thirty minutes.
The other 10 children in the comparison group will act as controls. At the clinic visit at baseline assessment, they will play the fishing game. There will be no further intervention subsequently.
ASSESSMENT
The following questionnaires will be administered to all subjects in both study groups at week 5, week 10, and at 3 months post-intervention (week 22):
- ADHD Rating Scale: parents and teachers
- Child Behaviour Checklist (CBCL): parents
- Teacher's Report Form (TRF): teachers
In addition, for those subjects in the intervention group, they will be given 2 worksheets (1 Maths and 1 short comprehension exercise) at the end of the intervention during visits 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20 over the 10-week period. Their EEG activity will be recorded during the completion of these worksheets.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 539747
- Institute of Mental Health/Woodbridge Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Satisfy DSM-IV-TR criteria for ADHD (Combined OR Inattentive subtype)
Exclusion Criteria:
- Present or history of medical treatment with stimulant medication and/or Atomoxetine
- Co-morbid severe psychiatric condition or known sensori-neural deficit, e.g. complete blindness or deafness
- History of epileptic seizures
- Known mental retardation (i.e. IQ 70 and below)
- Predominantly hyperactive/impulsive subtype of ADHD
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention
20 sessions of EEG biofeedback training
|
Newly-developed video games employing neurofeedback strategy to be played twice a week, 1 hour per session for a period of ten weeks.
Other Names:
Newly-developed video games employing neurofeedback strategy to be played once for 1 hour.
|
Placebo Comparator: Control
Only 1 session of EEG biofeedback training
|
Newly-developed video games employing neurofeedback strategy to be played twice a week, 1 hour per session for a period of ten weeks.
Other Names:
Newly-developed video games employing neurofeedback strategy to be played once for 1 hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reliable Change Index (RCI)on ADHD Rating Scale
Time Frame: week 0, 5, 10, 22
|
week 0, 5, 10, 22
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
CBCL Attention Problem Score Change
Time Frame: Week 5, 10, 22
|
Week 5, 10, 22
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daniel SS Fung, Institute of Mental Health, Singapore
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DSRB-A/07/472
- NHG Grant: SIG 08/018
- AV/SW/581/1107/I2R agreement
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
University Hospital Bispebjerg and FrederiksbergMental Health Services in the Capital Region, DenmarkRecruitingSleep Disturbance | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified Type | Attention-deficit Hyperactivity | Hyperkinetic Conduct DisorderDenmark
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Ataturk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
Clinical Trials on Brain-Computer Interface System
-
Instituto Nacional de RehabilitacionInstituto Tecnologico y de Estudios Superiores de MontereyRecruitingCervical Spinal Cord InjuryMexico
-
Instituto Nacional de RehabilitacionNational Council of Science and Technology, Mexico; Hospital General Dr. Manuel... and other collaboratorsRecruitingStroke | Stroke, IschemicMexico
-
Centre d'Investigation Clinique et Technologique...Association Française contre les Myopathies (AFM), ParisCompletedCommunication | Neuromuscular DiseaseFrance
-
Duke-NUS Graduate Medical SchoolNanyang Technological UniversityActive, not recruiting
-
Duke-NUS Graduate Medical SchoolSingapore General Hospital; Tan Tock Seng Hospital; National University, Singapore and other collaboratorsCompletedDementia | Mild Cognitive Impairment | Alzheimer's Disease | Age-Related Cognitive DeclineSingapore
-
Chinese University of Hong KongUnknown
-
University of HoustonThe University of Texas Health Science Center, Houston; TIRR Memorial HermannRecruitingStroke | HemiparesisUnited States
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHealthy | Cerebral Palsy | Amyotrophic Lateral Sclerosis | Spinal Cord Injury | Neuromuscular DiseaseUnited States
-
National Healthcare Group, SingaporeDuke-NUS Graduate Medical School; Agency for Science, Technology and Research; Singapore Clinical Research InstituteCompletedAttention Deficit Hyperactivity DisorderSingapore
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedHealthyUnited States